Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

二盐酸奎宁注射液 - NMPA Drug Approval Details

Approvals/NMPA/Quinine Dihydrochloride Injection

Approved

化学药品

Quinine Dihydrochloride Injection

昆药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 12, 2020
Approval ID: 7LeaeOPvCGR
Company: 昆药集团股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeOPvCGR
Approval Number: 国药准字H53020922
Generic Name: 二盐酸奎宁注射液
Generic Name En: Quinine Dihydrochloride Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1ml:0.5g
Reg Date: 2020-08-12
Company Name: 昆药集团股份有限公司
Production Company Name: 昆药集团股份有限公司
Production Company Address: 云南省昆明市西郊七公里
Company Detail Path: /organization/kpc-pharmaceuticals-inc
Production Company Detail Path: /organization/kpc-pharmaceuticals-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 12, 2020

Approval ID

7LeaeOPvCGR

Type

化学药品

Back to NMPA Approvals